Israeli biotech startup CytoReason announced Wednesday that it is collaborating with German multinational science and technology company, Merck KGaA, Darmstadt, Germany, to profile one of its leading immuno-oncology drugs.
Read more here.
Source: https://blog.ourcrowd.com/cytoreason-teams-up-with-merck-kgaa-on-cancer-drug-development/
More from OurCrowd Blog
[MigVax in The Jerusalem Post] Israel’s MigVax oral vaccine scores $4.3m. to fast-track development
Source Node: 1433137
Time Stamp: Nov 5, 2021
[OurCrowd in market watch] SoftBank Investing $25M in OurCrowd
Source Node: 1308646
Time Stamp: Oct 27, 2021
[Lemonade in Financial Buzz] “The Buzz” show: Lemonade Inc. (NYSE: LMND) Lemonade Car as it moves to insure cars
Source Node: 1471085
Time Stamp: Nov 2, 2021
[CropX in PR Newswire] CropX acquires Tule, further expands in California with new solutions for specialty crops and drip irrigation
Source Node: 1942347
Time Stamp: Jan 31, 2023
[HoneyBook and Autobrains in the Jerusalem Post] Tech Buzz: HoneyBook and Autobrains continue funding momentum
Source Node: 1433451
Time Stamp: Nov 4, 2021
[Axiom Space in NASA] NASA updates media on next private astronaut mission to space station
Source Node: 2044125
Time Stamp: Mar 31, 2023
[ThetaRay in The Paypers] ThetaRay launches SONAR for safe cross-border payments
Source Node: 872678
Time Stamp: May 25, 2021
[Tortuga Logic in Business Wire] Tortuga Logic appoints Dr. Mitchell Mlinar as new Vice President of Engineering
Source Node: 1882845
Time Stamp: Jan 11, 2022
[Cyabra in ABC News] How pro-Trump bots are sowing division in the Republican Party: Report
Source Node: 2061560
Time Stamp: Apr 13, 2023
[Intuition Robotics in Fortune] Loneliness is a public health emergency we can’t afford to ignore
Source Node: 1862126
Time Stamp: Dec 29, 2022
[The EVERY Company in Business Wire] Anne Hathaway makes first B2B investment, backing future of food leader The EVERY Co.
Source Node: 1936128
Time Stamp: Feb 1, 2023